Abstract Background and Objectives Neoadjuvant radiation (NRT) is frequently utilized in
soft tissue sarcomas to increase local control. Its utility in cutaneous and soft tissue …

Background Given the propensity for hematogenous metastases, neoadjuvant
chemotherapy (NAC) could treat occult metastatic disease early, potentially improving …

Objective Previous studies have highlighted the poor survival of patients with cutaneous
angiosarcoma of the head and neck. Therapeutic options are limited, and effective treatment …

Background Angiosarcoma is an aggressive tumor rising in incidence from use of
therapeutic radiation. Because of its relative rarity, prognostic factors have not been clearly …

Background The etiology of cutaneous angiosarcoma (cAS) may be idiopathic (I-cAS), or
arise secondary to radiotherapy (RT-cAS), in chronic lymphedema (ST-cAS), or related to …

Primary cutaneous and soft tissue angiosarcoma is a rare but highly aggressive malignancy.
To date, surgical resection is the mainstay of treatment, but poor prognosis is expected. To …

The most widely accepted treatment for cutaneous angiosarcoma (CAS) is wide local
excision and postoperative radiation to decrease the risk of recurrence. Positive surgical …

Purpose/Objective (s) Cutaneous angiosarcomas of the face and scalp are rare soft tissue
tumors with locally aggressive malignant potential. Previous studies have shown that …

Simple Summary Angiosarcoma is a rare type of soft tissue sarcoma with a progressive and
unpredictable disease course. Currently, surgery is the only well-defined treatment option …

Background The aim of the present analysis was to retrospectively evaluate outcomes in
patients with cutaneous angiosarcoma of the face/scalp treated curatively with surgery …